QUEST DIAGNOSTICS $DGX Q3’26 EARNINGS HIGHLIGHTS 🔹 Revenue: $3.10B (Est. $3.05B) 🟢; +10.0% YoY 🔹 Adj. EPS: $3.00 (Est. $2.86) 🟢; +15.4% YoY 🔹 GAAP EPS: $2.78; +28.7% YoY Raises FY26 Guide: 🔹 Revenue: $12.07B-$12.11B (Est. $12B) 🟢 🔹 Adj. EPS: $11.25-$11.35 (Est. $11.19) 🟢 🔹 GAAP EPS: $10.21-$10.31 🔹 Operating Cash Flow: ~$1.90B 🔹 Capex: ~$550M Cash Flow: 🔹 Operating Cash Flow: $611M; +8.8% YoY 🔹 Capex: $166M; +15.0% YoY Other Q3 Metrics: 🔹 Adj. Oper Income: $517M (Est. $487M) 🟢 🔹 Adj. Oper Margin: 16.7% 🔹 Requisition Volume: +14.5% YoY 🔹 Organic Requisition Volume: +14.4% YoY 🔹 Revenue per Requisition: -4.2% YoY Announcements: 🔹 Quest laboratory test panels with over 50 biomarkers will be available through Apple Health later this year 🔹 Definitive agreement to acquire select outreach lab assets from a leading health system in the Northeastern U.S. 🔹 Launched a new AD-Detect test panel with pTau217, amyloid beta and APOE 🔹 Advanced Project Nova to the solutions-build phase; first lab deployment expected in fall 2027 Comments: 🔸 “With these growth trends and our strong performance, we are raising our revenue and EPS guidance for the full year.”

🚨BREAKING: Quest Diagnostics has been hacked. The company confirmed unauthorized access to its Quanum Lab Services Manager system, used by clients to order tests and access lab results. Access has been suspended while the investigation continues. Core operations remain unaffected.

Edible medical diagnostics would be a boon for healthcare, but how to safely power them? “The Intelligence” learns of a dissolvable new battery technology

Ten innovations spanning diagnostics, AI, mobility, mitochondria and regenerative medicine have been recognized at a Hong Kong summit. #longevity# #AI# #diagnostics# #mitochondria# #regenerativemedicine#

The direct-to-consumer diagnostics company built its name on longevity biomarker panels. Now it’s betting its future on everything else. #longevity# #biomarkers# #diagnostics# #aging# #health#

Likewise the same is true for medical diagnostics. AI is going to be better at analyzing medical results and be able to look at much more biometrics than what your doctor has today. Which will lead to identifying diseases before they are symptomatic and that will be a net + for everyone except maybe hospitals?